Strapharm, a leading producer in food supplements based in Nantes (France) backed by M80, initiates its European buy & build strategy with the acquisition of Hedelab.
Hedelab is a CDMO based in Belgium with full-service and innovation capability like Strapharm. This partnership paves the way for the combined group to become a leading European one-stop shop CDMO for food supplements brands and retailers.
Kumulus Partners and Emendo Capital acted as exclusive financial advisers to the buyers (Strapharm/M80). Kumulus & Emendo conducted an in-depth target search in Belgium and the Netherlands identifying and contacting over 50 potential acquisition targets.
